USD 1.7
(13.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2022 | 47.79 Million USD | 118.16% |
2021 | 21.9 Million USD | 171.31% |
2020 | 8.07 Million USD | 22.98% |
2019 | 6.56 Million USD | -20.93% |
2018 | 8.3 Million USD | 62.25% |
2017 | 5.11 Million USD | 86.86% |
2016 | 2.73 Million USD | -81.79% |
2015 | 15.04 Million USD | 1062.44% |
2014 | 1.29 Million USD | -30.83% |
2013 | 1.87 Million USD | 2053.29% |
2012 | 86.88 Thousand USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 Q2 | 42.48 Million USD | -3.76% |
2023 Q1 | 44.14 Million USD | -7.65% |
2022 Q4 | 47.79 Million USD | -25.15% |
2022 Q2 | 57.71 Million USD | 132.54% |
2022 Q3 | 63.85 Million USD | 10.64% |
2022 FY | 47.79 Million USD | 118.16% |
2022 Q1 | 24.81 Million USD | 13.28% |
2021 Q4 | 21.9 Million USD | 135.19% |
2021 Q1 | 6.86 Million USD | -15.02% |
2021 FY | 21.9 Million USD | 171.31% |
2021 Q3 | 9.31 Million USD | 12.31% |
2021 Q2 | 8.29 Million USD | 20.87% |
2020 Q3 | 6.58 Million USD | -16.54% |
2020 Q1 | 8.43 Million USD | 28.45% |
2020 Q2 | 7.89 Million USD | -6.44% |
2020 Q4 | 8.07 Million USD | 22.61% |
2020 FY | 8.07 Million USD | 22.98% |
2019 Q3 | 7.24 Million USD | -37.49% |
2019 FY | 6.56 Million USD | -20.93% |
2019 Q4 | 6.56 Million USD | -9.4% |
2019 Q2 | 11.59 Million USD | 12.95% |
2019 Q1 | 10.26 Million USD | 23.62% |
2018 Q2 | 6.44 Million USD | 4.93% |
2018 Q1 | 6.14 Million USD | 19.99% |
2018 FY | 8.3 Million USD | 62.25% |
2018 Q4 | 8.3 Million USD | 14.18% |
2018 Q3 | 7.27 Million USD | 12.86% |
2017 Q1 | 3.01 Million USD | 10.08% |
2017 Q2 | 3.58 Million USD | 18.97% |
2017 Q3 | 4.87 Million USD | 35.99% |
2017 Q4 | 5.11 Million USD | 4.92% |
2017 FY | 5.11 Million USD | 86.86% |
2016 Q2 | 6.36 Million USD | -18.01% |
2016 FY | 2.73 Million USD | -81.79% |
2016 Q3 | 7.1 Million USD | 11.68% |
2016 Q4 | 2.73 Million USD | -61.46% |
2016 Q1 | 7.76 Million USD | -48.4% |
2015 Q2 | 2.32 Million USD | 15.21% |
2015 Q4 | 15.04 Million USD | 104.71% |
2015 Q3 | 7.34 Million USD | 216.04% |
2015 Q1 | 2.01 Million USD | 62.48% |
2015 FY | 15.04 Million USD | 1062.44% |
2014 Q4 | 1.24 Million USD | -4.02% |
2014 Q1 | 620.66 Thousand USD | 86.97% |
2014 FY | 1.29 Million USD | -30.83% |
2014 Q2 | 329.03 Thousand USD | -46.99% |
2014 Q3 | 1.29 Million USD | 293.27% |
2013 Q2 | 286.54 Thousand USD | 0.0% |
2013 Q3 | 1.87 Million USD | 552.88% |
2013 FY | 1.87 Million USD | 2053.29% |
2013 Q4 | 331.95 Thousand USD | -82.26% |
2012 Q4 | - USD | -100.0% |
2012 FY | 86.88 Thousand USD | 0.0% |
2012 Q3 | 86.88 Thousand USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
ANI Pharmaceuticals, Inc. | 111.19 Million USD | 57.018% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | -606.072% |
Collegium Pharmaceutical, Inc. | 32.33 Million USD | -47.823% |
Cosmos Health Inc. | 4.78 Million USD | -897.984% |
Dynavax Technologies Corporation | 53.29 Million USD | 10.313% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | -310.355% |
Pacira BioSciences, Inc. | 104.35 Million USD | 54.2% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -733.41% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -733.41% |
SCYNEXIS, Inc. | - USD | -Infinity% |
Safety Shot Inc | 1.86 Million USD | -2456.311% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -5802.265% |
Alpha Teknova, Inc. | 11.59 Million USD | -312.23% |
Bright Green Corporation | - USD | -Infinity% |
Esperion Therapeutics, Inc. | 65.62 Million USD | 27.169% |
Embecta Corp. | 152.1 Million USD | 68.577% |
PainReform Ltd. | - USD | -Infinity% |
Journey Medical Corporation | 10.2 Million USD | -368.293% |
Procaps Group, S.A. | 96.83 Million USD | 50.643% |
Theratechnologies Inc. | 6.06 Million USD | -687.9% |
Harrow Health, Inc. | 10.86 Million USD | -339.809% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -1657.779% |
Biofrontera Inc. | 10.9 Million USD | -338.155% |
DURECT Corporation | 2.21 Million USD | -2053.853% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 38.257% |
Cronos Group Inc. | 30.33 Million USD | -57.533% |
OptiNose, Inc. | 8.05 Million USD | -493.567% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | -4779399900.0% |
Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
RedHill Biopharma Ltd. | 5.69 Million USD | -738.634% |
Organogenesis Holdings Inc. | 28.25 Million USD | -69.164% |
Guardion Health Sciences, Inc. | 2.67 Million USD | -1685.282% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -936.89% |
Radius Health, Inc. | 278.64 Million USD | 82.848% |
Universe Pharmaceuticals INC | 3.34 Million USD | -1329.56% |
ProPhase Labs, Inc. | 3.84 Million USD | -1144.311% |
Phibro Animal Health Corporation | 265.91 Million USD | 82.026% |
Procaps Group S.A. | 96.83 Million USD | 50.643% |
Alvotech | 74.43 Million USD | 35.789% |
TherapeuticsMD, Inc. | - USD | -Infinity% |
Viatris Inc. | 3.46 Billion USD | 98.623% |
Rockwell Medical, Inc. | 5.87 Million USD | -714.069% |
Aytu BioPharma, Inc. | 12.63 Million USD | -278.327% |
SIGA Technologies, Inc. | 64.21 Million USD | 25.576% |
Tilray Brands, Inc. | 252.08 Million USD | 81.041% |
Lifecore Biomedical, Inc. | 39.97 Million USD | -19.548% |
Shineco, Inc. | 1.58 Million USD | -2908.703% |
PetIQ, Inc. | 159.3 Million USD | 69.999% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 31383.3% |
Incannex Healthcare Limited | -10.01 Million USD | 577.224% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | -24.789% |
Alimera Sciences, Inc. | 1.87 Million USD | -2443.587% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 37.68 Million USD | -26.822% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | -2867.851% |
Clever Leaves Holdings Inc. | 4.48 Million USD | -966.116% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -18690.495% |
Avadel Pharmaceuticals plc | 10.38 Million USD | -360.443% |
Hempacco Co., Inc. | 2.54 Million USD | -1779.709% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 74.43 Million USD | 35.789% |
Lantheus Holdings, Inc. | 64.02 Million USD | 25.356% |
Currenc Group, Inc. | 732.91 Thousand USD | -6421.119% |
Kamada Ltd. | 87.74 Million USD | 45.532% |
Indivior PLC | 141.79 Million USD | 66.295% |
Evoke Pharma, Inc. | 481.84 Thousand USD | -9819.06% |
Flora Growth Corp. | 8.5 Million USD | -461.754% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -18690.495% |
Evolus, Inc. | 10.99 Million USD | -334.57% |
HUTCHMED (China) Limited | 50.25 Million USD | 4.903% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 54.84% |
Akanda Corp. | 1.28 Million USD | -3613.903% |